Raphael Pharmaceutical (RAPH) Shares Outstanding (2020 - 2026)

Raphael Pharmaceutical has disclosed Shares Outstanding (Entity) across 7 years of filings, most recently posting $20.2 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) rose 2.8% year-over-year to $20.2 million; the TTM figure through Jun 2026 stood at $20.2 million (up 2.8% YoY), while the FY2025 annual figure was $20.2 million, up 7.89% from the prior year.
• Shares Outstanding (Entity) came in at $20.2 million for Q2 2026 at Raphael Pharmaceutical, roughly flat from $20.2 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $20.2 million in Q4 2025 to a low of $13.3 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $17.7 million, with a median of $18.7 million recorded in 2024.
• Year-over-year, Shares Outstanding (Entity) jumped 40.5% in 2022 and climbed 1.07% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $15.6 million in 2022, then climbed by 18.43% to $18.5 million in 2023, then rose by 1.07% to $18.7 million in 2024, then rose by 7.89% to $20.2 million in 2025, then changed by 0.0% to $20.2 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $20.2 million in Q2 2026, $20.2 million in Q4 2025, and $19.6 million in Q3 2025.